Clinical Trial: Study on the median effective dose (ED50) of Oxyrelidine combined with remifentanil in suppressing hysteroscopic surgery stimulation reactions (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the median effective dose (ED50) of Oxyrelidine combined with remifentanil in suppressing hysteroscopic surgery stimulation reactions'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135141

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: Yuebei People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342684

Published by HT Digital Content Services with permission from Health Daily Digest....